Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 4Myeloid 3Lymphoid 3CNS 3Thoracic 2Sarcoma 2Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1NET 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Prostatic Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 195pembrolizumab 158Pemetrexed 136Cisplatin 119durvalumab 73Paclitaxel 72osimertinib 68Nivolumab 66Docetaxel 63Specimen Handling 61atezolizumab 58Magnetic Resonance Spectroscopy 50Etoposide 47Gemcitabine 42Radiotherapy 39Radiosurgery 37130-nm albumin-bound paclitaxel 34Drug Therapy 30Cetuximab 28Bevacizumab 27Ipilimumab 25Taxes 23cemiplimab 22tislelizumab 21Platinum 20Radiation 19amivantamab 18Immunoglobulin G 171,2-diaminocyclohexaneplatinum II citrate 17Disulfides 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Photons × Thoracic × 90 days × Clear all
NCT07594522 2026-05-18

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
36 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
24 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡